Professional role
Psychiatry Resident[1]
TJ
Terence J. Meyerhoefer
About
Dr. Meyerhoefer’s project aims to investigate a novel diagnostic biomarker for schizophrenia that combines the power of artificial intelligence with optical coherence tomography images of the retina.
Research interests
artificial intelligence with optical coherence tomography images of the retina · novel diagnostic biomarker for schizophrenia
Research
Reviewed sources document artificial intelligence with optical coherence tomography images of the retina and novel diagnostic biomarker for schizophrenia. Publication attribution is still being resolved.
Explore researchEducation and career
Reviewed Sep 9, 2026Other education records
Education record
PGY-3[1]
Research
Research interests
artificial intelligence with optical coherence tomography images of the retina[1]
Research interests
novel diagnostic biomarker for schizophrenia[1]
Publications
0 attributed works. Counts reflect resolved authorship and may be incomplete.
No publications resolved yet.
Sources
Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.
- [1]Department of Psychiatry and Psychology Researchers
8 source claims · Reviewed Sep 9, 2026
Biographical context: Dr. Meyerhoefer’s project aims to investigate a novel diagnostic biomarker for schizophrenia that combines the power of artificial intelligence with optical coherence tomography images of the retina.
### Terence J. Meyerhoefer, M.D., M.S., PGY-3 – Psychiatry Resident Mentor: Matej Markota, M.D. Dr. Meyerhoefer’s project aims to investigate a novel diagnostic biomarker for schizophrenia that combines the power of artificial intelligence with optical coherence tomography images of the retina. Given the lack of current reliable tests to diagnose schizophrenia, this work has the potential to develop the first biomarker for schizophrenia, which could help to reduce the current two-year average delay between the onset of symptoms and treatment. **Visual description:** Professional headshot of a man with long brown hair and a beard, wearing a gray suit and tie, against a gray background.
Degree: M.D.
### Terence J. Meyerhoefer, M.D., M.S., PGY-3 – Psychiatry Resident Mentor: Matej Markota, M.D. Dr. Meyerhoefer’s project aims to investigate a novel diagnostic biomarker for schizophrenia that combines the power of artificial intelligence with optical coherence tomography images of the retina. Given the lack of current reliable tests to diagnose schizophrenia, this work has the potential to develop the first biomarker for schizophrenia, which could help to reduce the current two-year average delay between the onset of symptoms and treatment. **Visual description:** Professional headshot of a man with long brown hair and a beard, wearing a gray suit and tie, against a gray background.
Degree: M.S.
### Terence J. Meyerhoefer, M.D., M.S., PGY-3 – Psychiatry Resident Mentor: Matej Markota, M.D. Dr. Meyerhoefer’s project aims to investigate a novel diagnostic biomarker for schizophrenia that combines the power of artificial intelligence with optical coherence tomography images of the retina. Given the lack of current reliable tests to diagnose schizophrenia, this work has the potential to develop the first biomarker for schizophrenia, which could help to reduce the current two-year average delay between the onset of symptoms and treatment. **Visual description:** Professional headshot of a man with long brown hair and a beard, wearing a gray suit and tie, against a gray background.
Education record: PGY-3
### Terence J. Meyerhoefer, M.D., M.S., PGY-3 – Psychiatry Resident Mentor: Matej Markota, M.D. Dr. Meyerhoefer’s project aims to investigate a novel diagnostic biomarker for schizophrenia that combines the power of artificial intelligence with optical coherence tomography images of the retina. Given the lack of current reliable tests to diagnose schizophrenia, this work has the potential to develop the first biomarker for schizophrenia, which could help to reduce the current two-year average delay between the onset of symptoms and treatment. **Visual description:** Professional headshot of a man with long brown hair and a beard, wearing a gray suit and tie, against a gray background.
Identity: Terence J. Meyerhoefer
### Terence J. Meyerhoefer, M.D., M.S., PGY-3 – Psychiatry Resident Mentor: Matej Markota, M.D. Dr. Meyerhoefer’s project aims to investigate a novel diagnostic biomarker for schizophrenia that combines the power of artificial intelligence with optical coherence tomography images of the retina. Given the lack of current reliable tests to diagnose schizophrenia, this work has the potential to develop the first biomarker for schizophrenia, which could help to reduce the current two-year average delay between the onset of symptoms and treatment. **Visual description:** Professional headshot of a man with long brown hair and a beard, wearing a gray suit and tie, against a gray background.
Professional role: Psychiatry Resident
### Terence J. Meyerhoefer, M.D., M.S., PGY-3 – Psychiatry Resident Mentor: Matej Markota, M.D. Dr. Meyerhoefer’s project aims to investigate a novel diagnostic biomarker for schizophrenia that combines the power of artificial intelligence with optical coherence tomography images of the retina. Given the lack of current reliable tests to diagnose schizophrenia, this work has the potential to develop the first biomarker for schizophrenia, which could help to reduce the current two-year average delay between the onset of symptoms and treatment. **Visual description:** Professional headshot of a man with long brown hair and a beard, wearing a gray suit and tie, against a gray background.
Research interests: artificial intelligence with optical coherence tomography images of the retina
### Terence J. Meyerhoefer, M.D., M.S., PGY-3 – Psychiatry Resident Mentor: Matej Markota, M.D. Dr. Meyerhoefer’s project aims to investigate a novel diagnostic biomarker for schizophrenia that combines the power of artificial intelligence with optical coherence tomography images of the retina. Given the lack of current reliable tests to diagnose schizophrenia, this work has the potential to develop the first biomarker for schizophrenia, which could help to reduce the current two-year average delay between the onset of symptoms and treatment. **Visual description:** Professional headshot of a man with long brown hair and a beard, wearing a gray suit and tie, against a gray background.
Research interests: novel diagnostic biomarker for schizophrenia
### Terence J. Meyerhoefer, M.D., M.S., PGY-3 – Psychiatry Resident Mentor: Matej Markota, M.D. Dr. Meyerhoefer’s project aims to investigate a novel diagnostic biomarker for schizophrenia that combines the power of artificial intelligence with optical coherence tomography images of the retina. Given the lack of current reliable tests to diagnose schizophrenia, this work has the potential to develop the first biomarker for schizophrenia, which could help to reduce the current two-year average delay between the onset of symptoms and treatment. **Visual description:** Professional headshot of a man with long brown hair and a beard, wearing a gray suit and tie, against a gray background.